col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


74 Results       Page 1

 [1] 
MDPI AG: Current Issues in Molecular Biology
  original article Date Title Authors   All Authors
1 [GO] 2025―May―07 A Clinical Case of Multisystem Inflammatory Syndrome After SARS-CoV-2 Infection Associated with Group A β-Hemolytic Streptococcus Coinfection and Venous Thrombosis in a Child with Congenital Thrombophilia Zdravka Stoyanova, Katya Temelkova, Margarita Ganeva, Teodor Vasilev, Anna Dasheva-Dimitrova, Desislava Kibarova-Hristova, Stefan Stefanov
2 [GO] 2025―Apr―02 B Cell Dynamics and Transitional B Cells in Long COVID Zoia R. Korobova, Natalia A. Arsentieva, Natalia E. Liubimova, Oleg K. Batsunov, Anastasia A. Butenko, Albina E. Kokoeva, et al. (+8)
3 [GO] 2025―Mar―17 Structure-Based Identification of SARS-CoV-2 nsp10-16 Methyltransferase Inhibitors Using Molecular Dynamics Insights Ahmad M. Alharbi
4 [GO] 2025―Mar―12 Anti-Infective Screening of Selected Nine Cannabinoids Against Clostridium perfringens and Influenza A (H5N1) Neuraminidases, and SARS-CoV-2 Main Protease and Spike Protein Interactions Thanet Pitakbut, Oliver Kayser
5 [GO] 2025―Mar―11 The Legacy of COVID-19 in Breast Milk: The Association of Elevated Anti-Inflammatory and Antimicrobial Proteins with Vaccination or Infection Felicia Trofin, Petru Cianga, Daniela Constantinescu, Luminița Smaranda Iancu, Roxana Irina Iancu, Diana Păduraru, et al. (+5)
6 [GO] 2025―Feb―28 A Pilot Study on the Role of TRAFs in the Development of SARS-CoV-2 Infection Before and After Immunization with AstraZeneca Chadox1 in Mice Mounia Ammara, Inass Samiry, Younes Zaid, Mounia Oudghiri, Abdallah Naya
7 [GO] 2024―Nov―12 Computational Insights into Acrylamide Fragment Inhibition of SARS-CoV-2 Main Protease Ping Chen, Liyuan Wu, Bo Qin, Haodong Yao, Deting Xu, Sheng Cui, Lina Zhao
8 [GO] 2024―Nov―06 Benchmark Investigation of SARS-CoV-2 Mutants’ Immune Escape with 2B04 Murine Antibody: A Step Towards Unraveling a Larger Picture Karina Kapusta, Allyson McGowan, Santanu Banerjee, Jing Wang, Wojciech Kolodziejczyk, Jerzy Leszczynski
9 [GO] 2024―Oct―23 SARS-CoV-2 and Environmental Changes: The Perfect Storm Mario Caldarelli, Pierluigi Rio, Vincenzo Giambra, Ivana Palucci, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci
10 [GO] 2024―Oct―22 Impact of Hyponatremia and ADH Secretion in MIS-C and COVID-19: An Integrative Approach of Prognostic and Diagnostic Markers Diana-Andreea Ciortea, Carmen Loredana Petrea (Cliveți), Sorin Ion Berbece, Silvia Fotea, Iolanda Cristina Vivisenco, Gabriela Gurău, et al. (+2)
11 [GO] 2024―Oct―02 Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination Lina Souan, Hikmat Abdel-Razeq, Maher A. Sughayer
12 [GO] 2024―Aug―15 Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19 Marco Iuliano, Roberta Maria Mongiovì, Alberico Parente, Blerta Kertusha, Anna Carraro, Raffaella Marocco, et al. (+8)
13 [GO] 2024―Aug―10 A New Case of Paediatric Systemic Lupus Erythematosus with Onset after SARS-CoV-2 and Epstein-Barr Infection-A Case Report and Literature Review Carmen Loredana Petrea (Cliveți), Diana-Andreea Ciortea, Magdalena Miulescu, Iuliana-Laura Candussi, Sergiu Ioachim Chirila, Gabriela Isabela Verga (Răuță), et al. (+3)
14 [GO] 2024―Aug―06 Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors? Fabiana Amaral Guarienti, Fernando Antônio Costa Xavier, Mateus Duarte Ferraz, Fernanda Wagner, Daniel Rodrigo Marinowic, Jaderson Costa da Costa, Denise Cantarelli Machado
15 [GO] 2024―Jul―10 Preliminary Study on the Restoration of the Phospholipid Profile in Serum from Patients with COVID-19 by Treatment with Vitamin E María Elena Soto, Linaloe Manzano-Pech, Verónica Guarner-Lans, Adrían Palacios-Chavarría, Rafael Ricardo Valdez-Vázquez, Raúl Martínez-Memije, et al. (+3)
16 [GO] 2024―Jun―28 Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19 Jiaoyue Dong, Dingyuan Su, Binbin Zhao, Jiayang Han, Mengjie Tu, Kaifeng Zhang, et al. (+2)
17 [GO] 2024―Jun―21 MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development Farah Khaznadar, Omar Khaznadar, Ana Petrovic, Marija Hefer, Fabian Gjoni, Stefan Gjoni, et al. (+3)
18 [GO] 2024―Jun―10 Genomic Evolution Strategy in SARS-CoV-2 Lineage B: Coevolution of Cis Elements Yahaira de J. Tamayo-Ordóñez, Ninfa M. Rosas-García, Francisco A. Tamayo-Ordoñez, Benjamín A. Ayil-Gutiérrez, Juan M. Bello-López, Gerardo de J. Sosa-Santillán, et al. (+6)
19 [GO] 2024―May―10 SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease George D. Vavougios, Theodoros Mavridis, Triantafyllos Doskas, Olga Papaggeli, Pelagia Foka, Georgios Hadjigeorgiou
20 [GO] 2024―May―06 Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection Panagiotis Keramidas, Maria Pitou, Eleni Papachristou, Theodora Choli-Papadopoulou
21 [GO] 2024―May―03 Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves Panagiota Tsiatsiou, Kyriakos Kouirouxis, Vasiliki Tsaireli, Antonia Lanta, Angeliki Kassomenaki, Maria Papaioannou, et al. (+2)
22 [GO] 2024―Apr―18 CCN1-Mediated Signaling in Placental Villous Tissues after SARS-CoV-2 Infection in Term Pregnant Women: Implications for Dysregulated Angiogenesis Yuyang Ma, Liyan Duan, Beatrix Reisch, Rainer Kimmig, Antonella Iannaccone, Alexandra Gellhaus
23 [GO] 2024―Feb―29 COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19 Andrew Kemerley, Abhishek Gupta, Mahesh Thirunavukkarasu, Monica Maloney, Sean Burgwardt, Nilanjana Maulik
24 [GO] 2024―Jan―25 Disruption of the Functional Activity of Neutrophil Granulocytes as a Risk Factor for the Development of Lung Damage in Pregnant Women with COVID-19 Irina Anatolyevna Andrievskaya, Egor Mikhailovich Ustinov, Karen Sargisovich Lyazgian, Nataliya Alexandrovna Ishutina, Inna Victorovna Dovzhikova
25 [GO] 2024―Jan―24 An Expeditious Neutralization Assay for Porcine Reproductive and Respiratory Syndrome Virus Based on a Recombinant Virus Expressing Green Fluorescent Protein Juan Wang, Jiecong Yan, Shuaiyong Wang, Ronglin Chen, Yanru Xing, Qingyan Liu, et al. (+12)
26 [GO] 2024―Jan―02 Single-Cell RNA Sequencing Reveals Alterations in Patient Immune Cells with Pulmonary Long COVID-19 Complications Kristīne Vaivode, Rihards Saksis, Helēna Daiga Litvina, Helvijs Niedra, Marta Līva Spriņģe, Una Krūmiņa, et al. (+2)
27 [GO] 2023―Dec―18 In Silico Analysis of SARS-CoV-2 Non-Structural Proteins Reveals an Interaction with the Host’s Heat Shock Proteins That May Contribute to Viral Replications and Development Mthembu Yamkela, Zingisa Sitobo, Xolani H. Makhoba
28 [GO] 2023―Sep―29 The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2 Simona Fenizia, Melania Gaggini, Cristina Vassalle
29 [GO] 2023―Sep―29 Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2 Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, Shimrit Adutler-Lieber, Liat Bar-On, Erez Bar-Haim, et al. (+6)
30 [GO] 2023―Aug―28 Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities Asif Mahmood, Shahid Mehmood, Wen Zhang
31 [GO] 2023―Jul―19 A Clinical Qualification Protocol Highlights Overlapping Genomic Influences and Neuro-Autonomic Mechanisms in Ehlers-Danlos and Long COVID-19 Syndromes Golder N. Wilson
32 [GO] 2023―Jul―14 Genome-Wide Mining of Selaginella moellendorffii for Hevein-like Lectins and Their Potential Molecular Mimicry with SARS-CoV-2 Spike Glycoprotein Ahmed Alsolami, Amina I. Dirar, Emadeldin Hassan E. Konozy, Makarim El-Fadil M. Osman, Mohanad A. Ibrahim, Khalid Farhan Alshammari, et al. (+3)
33 [GO] 2023―Jul―03 Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System Cancers and Their Correlation with COVID-19 Zuming Xiong, Yongjun Yang, Wenxin Li, Yirong Lin, Wei Huang, Sen Zhang
34 [GO] 2023―May―08 Cycle Threshold (Ct) Values of SARS-CoV-2 Detected with the GeneXpert® System and a Mutation Associated with Different Target Gene Failure Keita Yamashita, Terumi Taniguchi, Noriyasu Niizeki, Yuki Nagao, Akira Suzuki, Akihiro Toguchi, et al. (+6)
35 [GO] 2023―Apr―05 Host-Based Treatments for Severe COVID-19 Lucrezia Mondini, Francesco Salton, Liliana Trotta, Chiara Bozzi, Riccardo Pozzan, Mariangela Barbieri, et al. (+6)
36 [GO] 2023―Apr―04 Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review Michele Montori, Gialuca Svegliati Baroni, Pierangelo Santori, Catia Di Giampaolo, Francesca Ponziani, Ludovico Abenavoli, Emidio Scarpellini
37 [GO] 2023―Apr―04 Endogenous piRNAs Can Interact with the Omicron Variant of the SARS-CoV-2 Genome Aizhan Rakhmetullina, Aigul Akimniyazova, Togzhan Niyazova, Anna Pyrkova, Saltanat Kamenova, Aida Kondybayeva, et al. (+3)
38 [GO] 2023―Mar―16 Immunohistochemical Analysis of Spermatogenesis in Patients with SARS-CoV-2 Invasion in Different Age Groups Grigory A. Demyashkin, Evgeniya Kogan, Tatiana Demura, Dmitry Boldyrev, Matvey Vadyukhin, Vladimir Schekin, et al. (+2)
39 [GO] 2023―Mar―01 Biomarker Profiles Associated with COVID-19 Severity and Mortality Silvia Sánchez-Díez, Carlos Gómez-Ollés, María-Jesús Cruz, Miquel de Homdedeu, David Espejo, Jaume Ferrer, et al. (+3)
40 [GO] 2023―Feb―10 Proof-of-Concept Analysis of B Cell Receptor Repertoire in COVID-19 Patients Undergoing ECMO by Single-Cell V(D)J and Gene Expression Sequencing Alessia Gallo, Nicola Cuscino, Claudia Carcione, Rosalia Busà, Pier Giulio Conaldi, Matteo Bulati
41 [GO] 2023―Feb―08 Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Cl믭 Pyridine Scaffolds as Potential COVID-19 Inhibitors Adel Alghamdi, Amr S. Abouzied, Abdulwahab Alamri, Sirajudheen Anwar, Mukhtar Ansari, Ibrahim Khadra, et al. (+2)
42 [GO] 2023―Jan―20 Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients Hasan Doğan, Aslı Kara, Erdem Çankaya, Eda Balkan, Muhammet Ali Gürbüz, Murat Kızılkaya, Merve Aykaç
43 [GO] 2023―Jan―12 In Vitro Antiviral Evaluations of Coldmix®: An Essential Oil Blend against SARS-CoV-2 Kemal Hüsnü Can Başer, Ayşe Esra Karadağ, Sevde Nur Biltekin, Murat Ertürk, Fatih Demirci
44 [GO] 2023―Jan―05 A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors Desh Deepak Singh, Ihn Han, Eun-Ha Choi, Dharmendra Kumar Yadav
45 [GO] 2023―Jan―02 Severe Acute Respiratory Syndrome Coronavirus-2 Delta Variant Study In Vitro and Vivo Hranush Avagyan, Sona Hakobyan, Arpine Poghosyan, Lina Hakobyan, Liana Abroyan, Elena Karalova, et al. (+6)
46 [GO] 2023―Jan―02 Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection Érika Pereira Zambalde, Thomaz Luscher Dias, Grazielle Celeste Maktura, Mariene R. Amorim, Bianca Brenha, Luana Nunes Santos, et al. (+17)
47 [GO] 2022―Dec―21 Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19 Jenny Valentina Garmendia, Alexis Hipólito García, Claudia Valentina De Sanctis, Marián Hajdúch, Juan Bautista De Sanctis
48 [GO] 2022―Dec―21 The Potential of Stilbene Compounds to Inhibit Mpro Protease as a Natural Treatment Strategy for Coronavirus Disease-2019 Ayesha Naseem, Fatima Rasool, Abrar Ahmed, Wayne G. Carter
49 [GO] 2022―Nov―28 Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer Takuma Hayashi, Kenji Sano, Nobuo Yaegashi, Ikuo Konishi
50 [GO] 2022―Nov―16 Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, Dharmendra Kumar Yadav, Eun Ha Choi
51 [GO] 2022―Oct―30 Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD) Subuhi Sherwani, Mohamed Raafat, Saravanan Rajendrasozhan, Mahvish Khan, Mohd Saleem, Qayyum Husain, et al. (+3)
52 [GO] 2022―Oct―20 Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study Heba Ali Hassan, Ahmed R. Hassan, Eslam A. R. Mohamed, Ahmad Al-Khdhairawi, Hala E. Taha, Hanan M. El-Tantawy, et al. (+10)
53 [GO] 2022―Oct―12 Era of Molecular Diagnostics Techniques before and after the COVID-19 Pandemic Ahmad M. Alamri, Faris A. Alkhilaiwi, Najeeb Ullah Khan
54 [GO] 2022―Oct―11 Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against? Maamoun Basheer, Elias Saad, Majd Kananeh, Layyous Asad, Osama Khayat, Anan Badarne, et al. (+6)
55 [GO] 2022―Sep―30 Synthesis and In Silico Study of Some New bis-[1,3,4]thiadiazolimines and bis-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main Protease Sobhi M. Gomha, Sayed M. Riyadh, Magda H. Abdellattif, Tariq Z. Abolibda, Hassan M. Abdel-aziz, AbdElAziz. A. Nayl, et al. (+2)
56 [GO] 2022―Jul―22 COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B Salvador García-Carmona, Ramcés Falfán-Valencia, Abigail Verónica-Aguilar, Ivette Buendía-Roldán, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, et al. (+11)
57 [GO] 2022―Jul―04 Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study Ahmad F. Eweas, Hosam-Eldin H. Osman, Ibrahim A. Naguib, Mohammed A. S. Abourehab, Ahmed S. Abdel-Moneim
58 [GO] 2022―Jun―29 Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection Eleni Gavriilaki, Stefanos A. Tsiftsoglou, Tasoula Touloumenidou, Evangelia Farmaki, Paraskevi Panagopoulou, Elissavet Michailidou, et al. (+17)
59 [GO] 2022―Jun―29 The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant Weeraya Thongkum, Kanyarat Thongheang, Chatchai Tayapiwatana
60 [GO] 2022―May―10 Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients Maura D’Amato, Valentina Vertui, Laura Pandolfi, Sara Bozzini, Tommaso Fossali, Riccardo Colombo, et al. (+6)
61 [GO] 2022―Apr―20 Revealing Potential Bioactive Compounds and Mechanisms of Lithospermum erythrorhizon against COVID-19 via Network Pharmacology Study Ki-Kwang Oh, Md. Adnan
62 [GO] 2022―Apr―12 Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115-1126 Hamid A. Merchant
63 [GO] 2022―Apr―08 Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19 Ki-Kwang Oh, Md. Adnan, Dong-Ha Cho
64 [GO] 2022―Feb―28 Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line Markus Aldén, Francisko Olofsson Falla, Daowei Yang, Mohammad Barghouth, Cheng Luan, Magnus Rasmussen, Yang De Marinis
65 [GO] 2022―Feb―07 Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis Jozef Nahalka
66 [GO] 2022―Jan―11 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mutational Pattern in the Fourth Pandemic Phase in Greece Panagiotis Halvatsiotis, Sofia Vassiliu, Panagiotis Koulouvaris, Kalliopi Chatzantonaki, Konstantinos Asonitis, Ekatherina Charvalos, et al. (+2)
67 [GO] 2022―Jan―06 Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer Takuma Hayashi, Kenji Sano, Ikuo Konishi
68 [GO] 2021―Dec―31 Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents Igor V. Kudryavtsev, Natalia A. Arsentieva, Oleg K. Batsunov, Zoia R. Korobova, Irina V. Khamitova, Dmitrii V. Isakov, et al. (+10)
69 [GO] 2021―Dec―22 Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review Antonio Molina-Carballo, Rafael Palacios-López, Antonio Jerez-Calero, María Carmen Augustín-Morales, Ahmed Agil, Antonio Muñoz-Hoyos, Antonio Muñoz-Gallego
70 [GO] 2021―Nov―18 A Comparative Study between Spanish and British SARS-CoV-2 Variants Jose A. Jimenez Ruiz, Cecilia Lopez Ramirez, Jose Luis Lopez-Campos
71 [GO] 2021―Nov―08 Strategy to Develop and Evaluate a Multiplex RT-ddPCR in Response to SARS-CoV-2 Genomic Evolution Laura A. E. Van Poelvoorde, Mathieu Gand, Marie-Alice Fraiture, Sigrid C. J. De Keersmaecker, Bavo Verhaegen, Koenraad Van Hoorde, et al. (+4)
72 [GO] 2021―Sep―23 A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis Katie-May McLaughlin, Denisa Bojkova, Joshua D. Kandler, Marco Bechtel, Philipp Reus, Trang Le, et al. (+7)
73 [GO] 2021―Aug―02 Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology Goldin John, Nikhil Shri Sahajpal, Ashis K. Mondal, Sudha Ananth, Colin Williams, Alka Chaubey, et al. (+2)
74 [GO] 2021―Jul―20 Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations Ahmad Qasem, Ameera M. Shaw, Erij Elkamel, Saleh A. Naser
 [1] 

74 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec